Pacific Biosciences of California, Inc. (PACB)
Largest Insider Buys in Sector
PACB Stock Price History Chart
PACB Stock Performance
About Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and …
Insider Activity of Pacific Biosciences of California, Inc.
Over the last 12 months, insiders at Pacific Biosciences of California, Inc. have bought $176,160 and sold $1.88M worth of Pacific Biosciences of California, Inc. stock.
On average, over the past 5 years, insiders at Pacific Biosciences of California, Inc. have bought $176,160 and sold $49.83M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Meline David W (director) — $528,480.
The last purchase of 40,000 shares for transaction amount of $176,160 was made by Meline David W (director) on 2024‑03‑06.
List of Insider Buy and Sell Transactions, Pacific Biosciences of California, Inc.
| 2024-09-30 | Sale | See Remarks | 19,782 0.0072% | $1.72 | $34,065 | +16.47% | ||
| 2024-09-16 | Sale | See Remarks | 98,907 0.0343% | $1.75 | $172,692 | +5.68% | ||
| 2024-08-19 | Sale | See Remarks | 26,760 0.0098% | $1.59 | $42,602 | +9.06% | ||
| 2024-08-16 | Sale | See Remarks | 38,011 0.0162% | $1.66 | $63,174 | 0.00% | ||
| 2024-05-20 | Sale | See Remarks | 5,275 0.002% | $2.03 | $10,708 | -6.25% | ||
| 2024-03-06 | director | 40,000 0.0158% | $4.40 | $176,160 | -55.74% | |||
| 2024-03-04 | Sale | See Remarks | 14,177 0.0053% | $4.87 | $69,056 | -62.09% | ||
| 2024-03-04 | Sale | See Remarks | 9,186 0.0034% | $4.87 | $44,745 | -62.09% | ||
| 2024-03-04 | Sale | See Remarks | 5,275 0.002% | $4.87 | $25,695 | -62.09% | ||
| 2024-03-04 | Sale | See Remarks | 2,968 0.0011% | $4.87 | $14,457 | -62.09% | ||
| 2024-02-20 | Sale | See Remarks | 1,979 0.0007% | $5.26 | $10,412 | -64.65% | ||
| 2024-02-20 | Sale | See Remarks | 831 0.0003% | $5.26 | $4,372 | -64.65% | ||
| 2024-02-16 | Sale | See Remarks | 79,038 0.0307% | $5.96 | $470,908 | -67.33% | ||
| 2024-02-16 | Sale | See Remarks | 33,560 0.013% | $5.96 | $199,950 | -67.33% | ||
| 2024-02-16 | Sale | See Remarks | 15,498 0.006% | $5.96 | $92,337 | -67.33% | ||
| 2024-02-16 | Sale | See Remarks | 22,496 0.0087% | $5.96 | $134,031 | -67.33% | ||
| 2024-02-16 | Sale | See Remarks | 7,562 0.0029% | $5.96 | $45,054 | -67.33% | ||
| 2024-01-09 | Sale | See Remarks | 31,012 0.0117% | $7.77 | $241,056 | -74.24% | ||
| 2023-12-14 | Sale | See Remarks | 20,000 0.0076% | $10.00 | $200,000 | -79.12% | ||
| 2023-09-29 | Sale | See Remarks | 19,257 0.0078% | $8.44 | $162,471 | -52.63% |
Insider Historical Profitability
| Meline David W | director | 40000 0.0146% | $1.70 | 1 | 0 | |
| Hunkapiller Michael | director | 848405 0.3098% | $1.70 | 20 | 28 | +56.73% |
| Phillips James Michael | SVP, Research & Development | 249220 0.091% | $1.70 | 8 | 7 | +5.88% |
| CORCORAN KEVIN P | SVP, Market Development | 40455 0.0148% | $1.70 | 3 | 0 | <0.0001% |
| Ericson William W. | director | 18795 0.0069% | $1.70 | 12 | 2 | +17.15% |
Institutional Investor Ownership
| ARK Investment Management LLC | $124.84M | 12.22 | 33.29M | -3.52% | -$4.55M | 0.43 | |
| The Vanguard Group | $99.77M | 9.77 | 26.61M | -0.68% | -$686,501.24 | <0.01 | |
| BlackRock | $87.73M | 8.59 | 23.39M | -5.06% | -$4.68M | <0.01 | |
| Madrone Advisors Llc | $65.97M | 6.46 | 17.59M | 0% | +$0 | 9.05 | |
| Nikko Asset Management Americas Inc | $47.96M | 4.71 | 12.82M | -2.85% | -$1.41M | 0.36 |